[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.167.142.229. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 376
Citations 0
Letters
February 20, 2013

Evaluating Other Diseases With Computed Tomographic Screening for Lung Cancer

Author Affiliations
 

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

Author Affiliations: Duke University School of Medicine, Durham, North Carolina (Dr Huesch; m.huesch@duke.edu); David Geffen School of Medicine, University of California, Los Angeles (Dr Ong); and School of Pharmacy, University of Southern California, Los Angeles (Dr Doctor).

JAMA. 2013;309(7):655-656. doi:10.1001/jama.2012.157205

To the Editor: In their Viewpoint, Dr Mets and colleagues1 proposed leveraging the data contained in low-dose non–contrast-enhanced chest computed tomography (CT) scans obtained for lung cancer screening to screen for cardiovascular disease (CVD). The authors acknowledged several conceptual (eg, false-positive findings and cost-effectiveness of the lung cancer screening) and operational difficulties (eg, lack of electrocardiography synchronization).

First Page Preview View Large
First page PDF preview
First page PDF preview
×